Randomized Phase II Trial Designs With Biomarkers

Journal of Clinical Oncology - United States
doi 10.1200/jco.2012.43.3946
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Randomized Phase II Designs

Clinical Cancer Research
Cancer ResearchOncology
2009English

Clinical Trial Designs Incorporating Predictive Biomarkers

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2016English

A Phase II, Randomized, Controlled Trial of Acupuncture for Reduction of Postcolectomy Ileus

Annals of Surgical Oncology
OncologySurgery
2012English

Randomized Phase II Trial of Survivin 2B Peptide Vaccination for Patients With HLA-A24-positive Pancreatic Adenocarcinoma

Cancer Science
Cancer ResearchMedicineOncology
2019English

A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Randomized Phase III Trial Comparing Surgery Alone to UFT + PSK for Stage II Rectal Cancer (JFMC38 Trial)

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2017English

Reply to “Phase II Prospective Randomized Trial of Weight Loss Prior to Radical Prostatectomy”

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2018English

Transplant Conditioning With Treosulfan/Fludarabine With or Without TBI. A Randomized Phase II Trial in Patients With MDS and AML

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy